ADVANCELL, INC.

Profile

Company Names

ADVANCELL, INC.

Addresses

245 MAIN STREET, CAMBRIDGE, MA 02142

Phone Numbers

+64 22 799 1300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2026

State Incorporated:

DELAWARE

Total Amount Raised:

$218,333,294.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2026-06-30 
$218,333,294.00 
$315,000,000.00 
$96,666,706.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW 
 
ADAMOVICH 
DIRECTOR
ADVANCELL ISOTOPES PTY LTD   |  ADVANCELL, INC.
ANTHONY 
 
AIUDI 
DIRECTOR
FOUNT BIO, INC.   |  BIOTHEA PHARMA, INC.   |  NEUTROLIS INC.   |  VALITOR, INC.   |  I2O THERAPEUTICS, INC.   |  ADVANCELL ISOTOPES PTY LTD   |  OTOLITH SOUND, INC.   |  ADVANCELL, INC.
JAMIL 
 
BEG 
DIRECTOR
NIDO BIOSCIENCES, INC.   |  KINASET THERAPEUTICS, INC.   |  ADVANCELL, INC.
KEVIN 
 
CAMERON 
DIRECTOR
AVIDBIOTICS CORP.   |  ECOTALITY, INC.   |  IONETIX CORP   |  PYLUM BIOSCIENCES, INC.   |  ADVANCELL ISOTOPES PTY LTD   |  IONETIX CORP / DE /   |  ADVANCELL, INC.
NIK 
 
ECONOMOPOULOS 
DIRECTOR
ADVANCELL, INC.
CHRISTOPHER 
 
GAGLIARDI 
DIRECTOR
I2O THERAPEUTICS, INC.   |  VERALOX THERAPEUTICS INC.   |  ADVANCELL, INC.
ANDREW 
 
KAY 
DIRECTOR
PHASE 17 INVESTMENTS, LP   |  PHASE 18 INVESTMENTS LP   |  ADVANCELL, INC.
WING CHEONG 
 
LAM 
DIRECTOR
ADVANCELL, INC.
PHILINA 
 
LEE 
EXECUTIVE OFFICER, DIRECTOR
ADVANCELL, INC.
BALI 
 
MURALIDHAR 
DIRECTOR
SPRUCE BIOSCIENCES, INC.   |  RENEO PHARMACEUTICALS, INC.   |  WUGEN, INC.   |  ADVANCELL, INC.   |  ALLOTERA THERAPEUTICS, INC.
AARON 
 
PICKETT 
EXECUTIVE OFFICER
ADVANCELL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#